Drosophila melanogaster as a model system for human brain cancers.

作者: Renee D. Read

DOI: 10.1002/GLIA.21148

关键词:

摘要: Glioblastomas (GBM), the most common primary brain tumors, infiltrate brain, grow rapidly, and are refractory to current therapies. Signature genetic lesions in glioblastomas include mutation of epidermal growth factor receptor tyrosine kinase (EGFR) activating mutations components PI-3 (PI3K) pathway. Despite years study, how these pathways specifically regulate glial pathogenesis is unclear. To address cellular origins this disease, a novel Drosophila GBM model has been developed which progenitor cells give rise proliferative invasive neoplastic that create transplantable tumors response constitutive co-activation EGFR-Ras PI3K pathways. Standing with rich literature demonstrating direct relevance studies on human cancer, neurological neurodevelopment, represents robust cell-type specific disease malignant created by thought be driving forces homologous disease. Using lineage analysis markers, were found originate from committed cells, rather than multipotent neuroblasts. Genetic analyses demonstrated induce fly neoplasia through activation combinatorial network composed, part, other also commonly mutated glioblastomas. In future, large-scale forward screens may reveal new insights into treatments glioblastoma. © 2011 Wiley-Liss, Inc.

参考文章(137)
R Endersby, S J Baker, PTEN signaling in brain: neuropathology and tumorigenesis Oncogene. ,vol. 27, pp. 5416- 5430 ,(2008) , 10.1038/ONC.2008.239
Ingo K Mellinghoff, Maria Y Wang, Igor Vivanco, Daphne A Haas-Kogan, Shaojun Zhu, Ederlyn Q Dia, Kan V Lu, Koji Yoshimoto, Julie HY Huang, Dennis J Chute, Bridget L Riggs, Steve Horvath, Linda M Liau, Webster K Cavenee, P Nagesh Rao, Rameen Beroukhim, Timothy C Peck, Jeffrey C Lee, William R Sellers, David Stokoe, Michael Prados, Timothy F Cloughesy, Charles L Sawyers, Paul S Mischel, None, Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. The New England Journal of Medicine. ,vol. 353, pp. 2012- 2024 ,(2005) , 10.1056/NEJMOA051918
Sally A. Prigent, Motoo Nagane, Hong Lin, Ivana Huvar, Gerry R. Boss, James R. Feramisco, Webster K. Cavenee, H.-J. Su Huang, Enhanced Tumorigenic Behavior of Glioblastoma Cells Expressing a Truncated Epidermal Growth Factor Receptor Is Mediated through the Ras-Shc-Grb2 Pathway Journal of Biological Chemistry. ,vol. 271, pp. 25639- 25645 ,(1996) , 10.1074/JBC.271.41.25639
W W Pong, D H Gutmann, The ecology of brain tumors: lessons learned from neurofibromatosis-1. Oncogene. ,vol. 30, pp. 1135- 1146 ,(2011) , 10.1038/ONC.2010.519
D. E. Comings, A General Theory of Carcinogenesis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 70, pp. 3324- 3328 ,(1973) , 10.1073/PNAS.70.12.3324
A. Buffo, I. Rite, P. Tripathi, A. Lepier, D. Colak, A.-P. Horn, T. Mori, M. Gotz, Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 105, pp. 3581- 3586 ,(2008) , 10.1073/PNAS.0709002105
M. B. Stark, A Benign Tumor that is Hereditary in Drosophila. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 5, pp. 573- 580 ,(1919) , 10.1073/PNAS.5.12.573
T. Stork, D. Engelen, A. Krudewig, M. Silies, R. J. Bainton, C. Klambt, Organization and Function of the Blood–Brain Barrier in Drosophila The Journal of Neuroscience. ,vol. 28, pp. 587- 597 ,(2008) , 10.1523/JNEUROSCI.4367-07.2008
Laura A. Buttitta, Alexia J. Katzaroff, Carissa L. Perez, Aida de la Cruz, Bruce A. Edgar, A Double-Assurance Mechanism Controls Cell Cycle Exit upon Terminal Differentiation in Drosophila Developmental Cell. ,vol. 12, pp. 631- 643 ,(2007) , 10.1016/J.DEVCEL.2007.02.020
Maria Luisa Sulis, Ramon Parsons, PTEN: from pathology to biology Trends in Cell Biology. ,vol. 13, pp. 478- 483 ,(2003) , 10.1016/S0962-8924(03)00175-2